PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Oct-2022 Athersys to Present at 2022 Cell & Gene Meeting on the Mesa Conference and Attend 14th World Stroke Congress in October Businesswire
04-Oct-2022 Governor McKee Announces Major Life Sciences Development Project to Move Forward in the I-195 Innovation and Design District Businesswire
04-Oct-2022 Global Chitosan Market Report Trends, Forecast and Competitive Analysis Report 2022 - ResearchAndMarkets.com Businesswire
04-Oct-2022 Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer Businesswire
04-Oct-2022 Oligomerix Awarded $2.49M from NIH to Further Support Clinical Development of Tau-Targeting Alzheimer’s Disease Therapy Candidate OLX-07010 Businesswire
04-Oct-2022 RAIN Alliance Names New President and CEO Businesswire
04-Oct-2022 Thermo Fisher Scientific Adds New Ultra-Low Temperature Chest Freezer to Green Portfolio, Offering Eco-Friendly, Compliant, and Secure Cold Storage Businesswire
04-Oct-2022 Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial Businesswire
04-Oct-2022 Global Precision and Personalized Medicine Thematic Research Report 2022 - ResearchAndMarkets.com Businesswire
04-Oct-2022 Evolus Broadens Its International Presence with Nuceiva® Launch in Great Britain Businesswire
04-Oct-2022 Global Aspirin Market Report 2022: Growing Demand for Branded Generics to Boost Sector - ResearchAndMarkets.com Businesswire
04-Oct-2022 Middle East Respiratory Syndrome (MERS) Drug Pipeline Market Insights Report 2022: 12+ Companies and 12+ Pipeline Drugs in the Pipeline Landscape - ResearchAndMarkets.com Businesswire
04-Oct-2022 Cyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease Businesswire
04-Oct-2022 Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology Businesswire
04-Oct-2022 Frazier Life Sciences Adds Experienced Biopharmaceutical Executive to Team Businesswire
04-Oct-2022 Exelixis Expands Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Include the Fixed-Dose Combination of Nivolumab and Relatlimab in Combination with XL092 in Phase 1b STELLAR-002 Trial Businesswire
04-Oct-2022 Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa Businesswire
04-Oct-2022 Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309 Businesswire
04-Oct-2022 Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022 Businesswire
04-Oct-2022 Abcuro Initiates Phase 1/2 Trial Evaluating ABC008 in Patients with T Cell Large Granular Lymphocytic Leukemia Businesswire